$35.20 -0.17 (-0.48%)
2/10/2012 4:00 PM

Endo Pharmaceuticals (NASDAQ:ENDP)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Featured Broker Partners


Advertisement